Orchestra Biomed Holdings Stock Widgets and Gadgets
| OBIO Stock | 5.57 0.20 3.47% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- OBIO Orchestra BioMed Holdings
- Latest Pivots Trading Plans and Risk Controls - Stock Traders Daily
- OBIO 5.57 -0.2
- Low 5.42
- High 5.94
- Alpha -0.41
- Beta 2.21
- Return On Equity -0.92
- Return On Asset -0.39
- Operating Margin (16.56) %
- Current Valuation 145.59 M
- Shares Outstanding 37.82 M
- Shares Owned By Insiders 22.14 %
- Shares Owned By Institutions 54.97 %
- Number Of Shares Shorted 778.62 K
- Price To Book 4.56 X
- Price To Sales 79.99 X
- Revenue 2.76 M
- EBITDA (51.22 M)
- Net Income (49.12 M)
- Total Debt 1.69 M
- Book Value Per Share 1.22 X
- Cash Flow From Operations (46.13 M)
- Short Ratio 17.03 X
- Earnings Per Share (1.60) X
- Target Price 15.6
- Number Of Employees 56
- Beta 0.41
- Market Capitalization 211.74 M
- Total Asset 95.21 M
- Retained Earnings (248.85 M)
- Working Capital 77.91 M
- Net Asset 95.21 M
- Accumulation Distribution 0.0875
- Daily Balance Of Power (0.38)
- Rate Of Daily Change 0.97
- Day Median Price 5.68
- Day Typical Price 5.64
- Market Facilitation Index 0.52
- Price Action Indicator (0.21)
- Period Momentum Indicator (0.20)
Market Snapshot Widget Example
DAX Index Germany | 19,405 0.43 | |
Taiwan Weighted Taiwan | 22,948 0.19 | |
PSI 20 Stock Portugal | 6,439 0.47 | |
CROBEX Croatia | 3,124 0.19 | |
Budapest SE Hungary | 79,472 0.1 | |
IDX 30 Jakarta Indonesia | 458.68 2.23 | |
ISEQ 20 Price Ireland | 1,615 0.28 | |
NYSE Comp USA | 20,220 0.48 | |
Tel Aviv 35 Israel | 2,281 0.93 | |
Coreshares Index Tracker South Afric | 1,100 0.09 | |
IPC MEXICO Mexico | 50,228 0.42 | |
KL Technology Malaysia | 60.32 1.96 | |
IBEX 35 Index Spain | 11,712 0.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,543 0.29 | |
SPASX Dividend Opportunities Australia | 1,697 0.26 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.53 | |
AMS Small Cap Netherlands | 1,188 0.40 | |
Oslo Exchange Mutual Norway | 1,426 0.25 | |
BEL Small Belgium | 8,148 0.53 | |
Basic Materials Brazil | 5,781 0.32 | |
Swiss Leader Price Switzerland | 1,933 0.06 | |
Fondo Mutuo ETF Chile | 1,368 0.41 | |
Athens General Comp Greece | 1,406 0.33 | |
Stock Exchange Of Thailand | 1,443 0.21 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,850 1.03 | |
WIG 30 Poland | 2,826 0.44 | |
BIST Electricity Turkey | 493.66 0.85 |
Investing Ideas
In addition to having Orchestra BioMed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Orchestra BioMed
Compare Orchestra BioMed To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orchestra BioMed Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orchestra BioMed. If investors know Orchestra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orchestra BioMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Revenue Per Share 0.073 | Quarterly Revenue Growth 1.356 | Return On Assets (0.39) | Return On Equity (0.92) |
The market value of Orchestra BioMed Holdings is measured differently than its book value, which is the value of Orchestra that is recorded on the company's balance sheet. Investors also form their own opinion of Orchestra BioMed's value that differs from its market value or its book value, called intrinsic value, which is Orchestra BioMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orchestra BioMed's market value can be influenced by many factors that don't directly affect Orchestra BioMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orchestra BioMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orchestra BioMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orchestra BioMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.